Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
|
|
Reuters (12.19.02) - Friday, December 20, 2002
Manoah Esipisu
The ANC said it was readying a comprehensive battle plan to fight the disease, which infects almost 5 million South Africans, or one person in nine. However, Mbeki, elected this week to lead the ANC for another five years, made only slight reference to AIDS in his keynote address to the conference, and suggested that TB was a more serious problem.
Joel Netshitenzhe, chief government spokesperson, assured reporters that the ANC realized the AIDS problem had ballooned since the last party conference in 1997. He said the ANC would have an "appropriate resolution" on the AIDS problem by the time the conference closed Friday.
Kgolema Motlanthe, ANC secretary-general, said the ANC envisioned a multiple strategy including AIDS drugs and measures to alleviate poverty. In the past, the government has dragged its heels on providing antiretroviral drugs through public hospitals, arguing that they were expensive, unproven, and toxic. Recent pilot programs showing that such drugs can dramatically improve AIDS patients' health may have helped influence the party's new commitment to anti-AIDS activism. South Africa has the world's highest single-country AIDS caseload, and AIDS has become increasingly visible as a social, political and economic problem.
Despite the ANC's promise of a new stance, an article in the British Guardian caused some to doubt the government's intentions. The piece quoted Health Minister Manto Tshabalala- Msimang as saying South Africa could not afford AIDS drugs because it needs the money to defend itself against potential aggressors, including the United States. She vehemently denied the report on Thursday, calling it "bizarre" and "distorted," and saying she never suggested that the United States could invade South Africa.
021220
AD022468
Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.